Lifting Depression: The Chromium Connection

Front Cover
Basic Health Publications, Inc., 2005 - 210 pages
People suffering from atypical depression typically don't respond to common antidepressants. Moreover, monomine oxidase inhibitors (MAOI's), which have been used as a treatment have such dangerous side effects that they are rarely used. Dr. McLeod discovered that atypical depression is triggered by insulin resistance, a condition in which the body does not respond to insulin efficiently, and that supplemental chromium, a trace mineral needed by the body to help insulin work properly, could bring fast, safe, effective relief in people who had suffered from depression for as long as twenty or thirty years.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Life Is a Burden
xi
Looking for Causes
7
Formulating a Treatment Plan
13
Taking the Back Roads
17
The Lonq Way Home
20
Murder of the Senses A Trial of an Antidepressant Medication
25
A Ray of Light
31
Needle in a Haystack
41
A Lock and a Key NormalandrAbnormal Glucose Metabolism
87
Sadness and Long Sorrow The Connection Between Impaired Glucose Metabolism and Depression
93
An Under an in Experience
103
Joseph Insulin Resistance Syndrome
115
The Sky Turns Clear and Blue
123
Help from Experts
130
Proof Evaluating Chromium Alone in the Treatment of Atypical Depression
136
A Grateful Psychiatrist
143

Land Ahoy
46
Elizabeth A Careful Observer
55
Do No Harm
60
Sara Lost and Wounded
68
Giving Sorrow Words
75
A Prepared Mind Discovering Chromiums Essential Role in Glucose Metabolism
83
Our Paths Crossed for a Moment
156
Putting It All Together
163
Glossary
177
Internet Resources
177
Index
191
Copyright

Other editions - View all

Common terms and phrases

Popular passages

Page vi - To wrest from nature the secrets which have perplexed philosophers in all ages, to track to their sources the causes of disease, to correlate the vast stores of knowledge, that they may be quickly available for the prevention and cure of disease - these are our ambitions.

About the author (2005)

His research findings have been published in The International Journal of Neuropsychopharmacology, The Journal of Clinical Psychiatry, and Biological Psychiatry. Dr. McLeod is Clinical Professor of Psychiatry at the University of North Carolina School of Medicine in Chapel Hill where he also maintains a p;rivate practice in psychiatry and psychoanalysis.

Bibliographic information